Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HNSBF - Hansa Biopharma AB's (HNSBF) CEO Søren Tulstrup on Q1 2022 Results - Earnings Call Transcript

HNSBF - Hansa Biopharma AB's (HNSBF) CEO Søren Tulstrup on Q1 2022 Results - Earnings Call Transcript

Hansa Biopharma AB
Hansa Biopharma AB (publ) (HNSBF) Q1 2022 Earnings Conference Call April 21, 2022 8:00 AM ET Company Participants Søren Tulstrup – Chief Executive Officer Conference Call Participants Adam Karlsson – ABG Douglas Tsao – H.C. Wainwright Christopher Uhde – SEB Dominic Rose – Intron Health Zoe Karamanoli – RBC Capital Market Presentation Operator Hello everyone and welcome to Hansa Biopharma First quarter 2022 Conference Call. My name is Juan and I will be coordinating your call today. [Operator Instructions] Now I will hand over to your host Søren Tulstrup, CEO of Hansa Biopharma. Please Søren go ahead. Søren Tulstrup Thank you, operator. Good afternoon, good morning and welcome to the Hansa Biopharma first quarter 2022 conference call. I’m Søren Tulstrup, CEO of Hansa Biopharma. And joining me today is Hansa’s Head of Investor Relations, Klaus Sindahl; our CFO, Donato Spota, was also scheduled to join us today. However, as his

For further details see:

Hansa Biopharma AB's (HNSBF) CEO Søren Tulstrup on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Hansa Biopharma AB
Stock Symbol: HNSBF
Market: OTC
Menu
HNSBF HNSBF Quote HNSBF Short HNSBF News HNSBF Articles HNSBF Message Board
Get HNSBF Alerts

News, Short Squeeze, Breakout and More Instantly...